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Abstract
Background: Sonic hedgehog (Shh) and components of its signalling pathway have been identified in human prostate carcinoma
and increased levels of their expression appear to correlate with disease progression and metastasis. The mechanism through
which Shh signalling could promote metastasis in bone, the most common site for prostate carcinoma metastasis, has not yet
been investigated. The present study determined the effect of Shh signalling between prostate cancer cells and pre-osteoblasts
on osteoblast differentiation, a requisite process for new bone formation that characterizes prostate carcinoma metastasis.
Results: LNCaP human prostate cancer cells modified to overexpress Shh (designated LNShh cells) and MC3T3 mouse pre-
osteoblasts were maintained as mixed populations within the same culture chamber. In this non-conventional mixed culture
system, LNShh cells upregulated the expression of Shh target genes Gli1 and Patched 1 (Ptc1) in MC3T3 cells and this was
inhibited by cyclopamine, a specific chemical inhibitor of hedgehog signalling. Concomitantly, MC3T3 cells exhibited time-
dependent decreased cell proliferation, upregulated alkaline phosphatase Akp2 gene expression, and increased alkaline
phosphatase activity indicative of early phase osteoblast differentiation. LNShh cell-induced differentiation was inhibited in
MC3T3 cells stably transfected with a dominant negative form of Gli1, a transcription factor that mediates Shh signalling.
Interestingly, LNShh cells did not significantly increase the endogenous expression of the osteoblast differentiation transcription
factor Runx2 and its target genes osteocalcin and osteopontin. Consistent with these results, exogenous Shh peptide did not
upregulate Runx2 expression in MC3T3 cells. However, Runx2 levels were increased in MC3T3 cells by ascorbic acid, a known
stimulator of osteoblast differentiation.
Conclusion: Altogether, these data demonstrate that Shh-expressing prostate cancer cells can directly and specifically induce
differentiation in pre-osteoblasts via a Gli1-dependent mechanism that does not require transcriptional upregulation of Runx2.
Paracrine activation of the Shh pathway in osteoblast progenitors and subsequent induction of osteoblast differentiation could
be a mechanism through which high levels of Shh expression in prostate carcinoma contribute to bone metastasis. Targeting of
paracrine Shh signalling may provide an effective therapeutic strategy against prostate carcinoma metastasis in bone.
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Background
Bone is the most common site for metastasis of prostate
carcinoma affecting as many as 90% of patients with met-
astatic disease [1]. Complications from skeletal metastasis
result in a dramatic reduction in the patient's quality of
life and invariably lead to death [2,3]. A clear understand-
ing of the factors and mechanisms that promote the
migration of prostate cancer cells to bone, their coloniza-
tion of the bone environment and subsequent formation
of metastases is critically needed to prevent and effectively
treat this disease. The commonly held "seed and soil" the-
ory emphasizes the importance of the bone microenvi-
ronment in determining the colonization success of
neoplastic "seed" cells [4]. On the other hand, prostate
cancer cells can alter gene expression and cell functions in
osteoblasts, suggesting that invading tumor cells might
also influence the host bone milieu making it a favourable
"soil" for metastasis [5,6]. This latter view fuels the on-
going search for factors secreted by prostate cancer cells
that might uniquely signal to bone and promote metas-
tases.
Sonic hedgehog (Shh) is a secreted glycopeptide that plays
essential functions in development and disease [7,8]. The
binding of Shh to its transmembrane receptor Patched 1
(Ptc1) triggers the release of the transmembrane protein
Smoothened (Smo) from Ptc1-mediated inhibition. Sub-
sequent activation of the intracellular signalling cascade
leads to the transcriptional regulation of Shh target genes
by the Gli family of transcription factors: Gli1, Gli2, and
Gli3.
Shh and members of its signalling pathway are expressed
in prostate carcinoma and increased levels of their expres-
sion appear to correlate with cancer progression and
metastasis [9-12]. Shh expression has been localized in
prostatic epithelia or glandular lumens of prostate tumors
indicating that epithelial-derived prostate cancer cells are
a primary if not sole source of the Shh protein [9,11].
We have shown previously that Shh-expressing human
prostate cancer cells upregulated Gli1 expression in sur-
rounding tumor stroma and accelerated tumor growth in
a mouse xenograft model of human prostate cancer [9].
This apparent paracrine activation of the pathway in pros-
tate tumorigenesis is highly reminiscent of Shh-Gli signal-
ling at epithelial-mesenchymal boundaries in several
developing organ systems including the prostate that pro-
motes cell proliferation and morphogenesis [13,14].
The mechanism by which Shh-Gli signalling could pro-
mote prostate carcinoma metastasis in bone has not been
previously determined. The present study provides evi-
dence of direct and specific paracrine Shh-Gli signalling
between prostate cancer cells and pre-osteoblasts which
leads to osteoblast differentiation, a requisite process for
osteoblastic metastasis.
Results
Shh-expressing human prostate cancer cells, LNShh, 
directly activate hedgehog signalling in MC3T3 pre-
osteoblasts
Paracrine interactions between cells have traditionally
been studied in vitro by co-culturing cells in separate
chambers while sharing the same culture medium. We
have developed a non-conventional mixed culture system
where different cell populations are cultured within the
same chamber, thus, allowing them to establish physical
associations that most likely occur in vivo and influence
cell-cell signalling.
Shh-expressing LNCaP human prostate cancer cells
obtained via stable transfection with hShh cDNA cloned
into a pIRES2-EGFP vector, designated as LNShh cells, or
vector-transfected control LNCaP cells were cultured
within the same culture chamber with MC3T3 mouse pre-
osteoblasts. The cells in this mixed culture system estab-
lished, in a time-dependent manner, a distinctive mor-
phologic pattern. There were no apparent differences in
the spatial organization of the mixed cultures of MC3T3
cells and either control LNCaP or LNShh cells, and only
images of mixed cultures of MC3T3 and LNShh cells are
shown in Figure 1. Beginning about two weeks of mixed
culture, clusters of LNShh cells, identified by their GFP
fluorescence, were surrounded by a compact "stroma" of
MC3T3 cells which exhibited more intense phalloidin
staining of their F-actin filaments (Figure 1, panels a, b
and c). Identification of the epithelial-derived LNShh cells
in mixed cultures was further confirmed by their positive
immunostaining for human cytokeratin 8 (Figure 1, panel
d). When cultured alone, LNShh cells also formed colo-
nies which became interconnected over time forming a
meshwork instead of remaining discrete as shown in
mixed cultures. On the other hand, single cultures of
MC3T3 cells which reached confluence at about two
weeks formed a sheet of cells instead of the reticulate net-
work evident in mixed cultures (data not shown).
To demonstrate activation of Shh signalling in pre-osteob-
lasts by Shh-expressing prostate cancer cells in mixed cul-
tures, the expression of known Shh target genes Gli1 and
Ptc1 were determined by quantitative real time RT-PCR
analysis using species specific primer sequences (Table 1)
which amplified these genes in mouse MC3T3 cells but
not in the human prostate cancer cells. Thus, amplifica-
tion of Gli1 and Ptc1 in mixed cultures is highly, if not
solely, attributable to their expression in MC3T3 mouse
pre-osteoblasts. Conversely, using primers that amplified
genes in human but not mouse cells, we determined that
expression of human GLI1 did not differ significantly
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between control LNCaP and LNShh cells cultured with
MC3T3 cells suggesting the absence of significant auto-
crine or feedback paracrine regulation of the hedgehog
pathway, at least under conditions used in these studies
(data not shown). We have previously used species-spe-
cific primers in RT-PCR analysis to demonstrate the upreg-
ulation of mouse Gli1 in mouse xenografts of human
prostate carcinoma [9].
MC3T3 pre-osteoblasts in mixed cultures with LNShh
cells expressed increased levels of Gli1 and Ptc1 compared
to those cultured with control LNCaP cells (Figure 2A). In
a traditional co-culture system where cells were grown in
separate chambers but shared the same culture medium,
MC3T3 cells co-cultured with LNShh cells also expressed
higher levels of Gli1 and Ptc1 (Figure 2B). Serum-free con-
ditioned media from single confluent cultures of LNShh
cells also increased Gli1 and Ptc1 expression in MC3T3
cells cultured alone which is consistent with the soluble
nature of the secreted Shh ligand (data not shown).
Morphologic pattern of LNShh human prostate cancer cells and MC3T3 mouse pre-osteoblasts in mixed cultureFigure 1
Morphologic pattern of LNShh human prostate cancer cells and MC3T3 mouse pre-osteoblasts in mixed cul-
ture. MC3T3 cells were mixed with Shh-expressing LNShh cells then seeded onto chamber slides and maintained for 14 days. 
(Panels a, b and c) GFP-expressing LNShh cells (stably transfected with pIRES2-hShh-EGFP vector) formed clusters surrounded 
by a stroma of MC3T3 cells which expressed intense phalloidin staining. DAPI was used as counterstain. Cells were visualized 
by fluorescent microscopy. (Panel d) LNShh cells in mixed culture were further identified by positive immunocytochemical 
staining for human cytokeratin 8 which was not detected in surrounding MC3T3 cells. Hematoxylin was used as counterstain. 
Scale bars: 50 μm.
Table 1: Sequences (5'- 3') of primers and probes used in quantitative real time RT-PCR analysis of mouse (m) and human (h) gene 
expression.
Gene Forward Primer Probe Reverse Primer
mGli1 GGAAGTCCTATTCACGCCTTGA TCAAGACGCACCTTCGGTCGCAC CAACCTTCTTGCTCACACATGTAAG
mPtc1 CTCCAAGTGTCGTCCGGTTT CGTGCCTCCTGGTCACACGAACAA ACACCGTGGTCTGAGAGCTGTAC
mAkp2 TCAGGGCAATGAGGTCACATC CGCTGGGCCAAGGATGCTGG CACCCGAGTGGTAGTCACAATG
mRunx2 CGAAATGCCTCCGCTGTTAT TAGCCAGGTTCAACGAT CGCTCCGGCCCACAA
mOcn GGCCCTGAGTCTGACAAAGC TTCATGTCCAAGCAGGAGGGCA GCCGGAGTCTGTTCACTACCTT
mOpn CATGAAGAGCGGTGAGTCTAAGG TCCCTCGATGTCATCCCTGTTGCC CTTTCCGTTGTTGTCCTGATCA
mGapdh AACCTGCCAAGTATGATGACATCA TGAAGCAGGCATCTGAGGGCCC CTGTTGAAGTCGCAGGAGACAA
hSHH AAGGACAAGTTGAACGCTTTGG ATCTCGGTGATGAACCAGTGGCCAG TCGGTCACCCGCAGTTTC
hGLI1 GGGCACCATCCATTTCTACAGT AGCCCAAGAGGGAGCGGGAAGG TCAGTCTGCTTTCCTCCCTGAT
hGAPDH CGACAGTCAGCC GCATCTT CGCCAGCCGAGCCACATCG TGACCAGGCGCCCAATAC
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Cyclopamine, a specific chemical inhibitor of hedgehog
signalling through functional inhibition of the Shh recep-
tor complex protein Smo, dramatically abrogated the
increase in both Gli1 and Ptc1 expression in MC3T3 cells
in mixed culture with LNShh cells (Figure 2C). Activation
of the hedgehog pathway in MC3T3 cells was a direct and
immediate effect of Shh action since exogenous Shh pep-
tide (Shh-N) increased Gli1 and Ptc1 message as early as
24 h following treatment (Figure 2D).
These data demonstrate specific and direct paracrine acti-
vation of Shh signalling in pre-osteoblasts by Shh-express-
ing prostate cancer cells.
LNShh cells upregulate Gli1 and Ptc1 expression in co-cultured MC3T3 cellsFigure 2
LNShh cells upregulate Gli1 and Ptc1 expression in co-cultured MC3T3 cells. In this and subsequent graphs, gene 
expression in MC3T3 cells was determined by quantitative real time RT-PCR analysis using mouse species-specific primers 
shown in Table 1. (A) MC3T3 cells were mixed with either LNCaP or LNShh cells then seeded onto 6-well plates (mixed cul-
tures). Expression of Gli1 and Ptc1 in MC3T3 cells cultured with LNShh cells (filled bars) relative to those cultured with control 
LNCaP cells (open bars) were compared. (B) MC3T3 cells were grown on 6-well plates in the presence of culture inserts con-
taining either LNCaP or LNShh cells (separate co-cultures). Expression of Gli1 and Ptc1 in MC3T3 cells co-cultured with 
LNShh cells (hatched bars) relative to those co-cultured with control LNCaP cells (open bars) were compared. (C) Effect of 
cyclopamine inhibition of paracrine Shh signalling. MC3T3 cells were maintained for 7 days in mixed culture with either LNCaP 
or LNShh cells in serum-free culture media without or with 1 μM and 10 μM cyclopamine. Expression of Gli1 and Ptc1 in 
MC3T3 cells cultured with LNShh cells in the absence or presence of cyclopamine (filled bars) relative to those cultured with 
control LNCaP cells without cyclopamine (open bars) were compared. (D) Effect of exogenous Shh peptide. MC3T3 cells were 
cultured alone in serum-free culture media without or with 1 μg/ml Shh-N (modified active N-terminal peptide of human Shh; 
kindly provided by Curis, Inc.). Relative expression of Gli1 and Ptc1 in MC3T3 cells treated without (open bars) or with (filled 
bars) Shh-N were compared. Data are means ± SD of 2–4 assays. *, P < 0.05.
(D)
(A) (B)
(C)
μM Cyclopamine
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LNShh cells induce early phase osteoblast differentiation
The ability of LNShh cells to induce osteoblast differenti-
ation was examined. The initial phase of osteoblast differ-
entiation is characterized by cell proliferation followed by
growth arrest [15]. As shown in Figure 3A, proliferation of
MC3T3 cells co-cultured with LNShh cells was signifi-
cantly decreased by days 5 and 7 of co-culture compared
to that of MC3T3 cells co-cultured with control LNCaP
cells or cultured alone. These data suggest that Shh-
expressing prostate cancer cells can inhibit cell prolifera-
tion in pre-osteoblasts.
Cell proliferation arrest is associated with a time-depend-
ent increase in alkaline phosphatase (ALP) activity, a well-
established indicator of osteoblast differentiation [15].
ALP activity in mixed cultures of MC3T3 and LNShh cells
increased with time and was significantly higher relative
to that in mixed cultures of MC3T3 and control LNCaP
cells (Figure 3B). Staining for ALP activity was performed
to determine the spatial localization of activity in mixed
cultures. Consistent with data shown in Figure 3B, stain-
ing for ALP activity was greater in mixed cultures of LNShh
and MC3T3 cells and intensified progressively through
time (Figure 3C). Staining for ALP activity was localized
almost exclusively in MC3T3 cells which surrounded clus-
ters of LNShh cells (Figure 3C). Single cultures of MC3T3
cells also exhibited ALP staining when grown to conflu-
ence (data not shown).
Correspondingly, expression of the alkaline phosphatase
gene Akp2, an early osteoblast differentiation marker
gene, was increased in MC3T3 cells in mixed culture with
LNShh cells, and this effect was mimicked by direct treat-
ment of MC3T3 cells with exogenous Shh-N (Figures 3D
and 3E, respectively).
MC3T3 cells in mixed culture with either control LNCaP
or LNShh cells in ascorbic acid (AA)-free α-MEM media
for 21 days were negative for both Alizarin red and Von
Kossa staining indicating the absence of significant cal-
cium deposition in and mineralization of the extracellular
matrix (ECM), respectively (data not shown). These
results are consistent with the known requirement for AA
and inorganic phosphates for ECM mineralization during
late stage osteoblast differentiation.
Gli1 transcriptional activity is required for LNShh cell-
induced osteoblast differentiation
To establish that LNShh cell-induced osteoblast differen-
tiation occurred via the Shh signalling pathway, MC3T3
cells were stably transfected with human GLI1 cDNA
which has a deletion in the region containing the trans
activation domain: pCMV-GLI(-)TAD [16]. The translated
GLI1 protein in transfected MC3T3 cells, designated as M-
TAD cells, is expected to bind to the consensus DNA Gli
LNShh cells induce osteoblast differentiationFigure 3
LNShh cells induce osteoblast differentiation. (A) 
Effect on cell proliferation. MC3T3 cells were grown in 24-
well plates with culture inserts containing either control 
LNCaP cells (squares), LNShh cells (triangles), or no cells 
(circles). Absorbance measurements are in direct proportion 
to the number of living cells. Each point is the mean ± SD of 
3 replicate wells, and results are representative of two inde-
pendent experiments. *P < 0.05 and **P < 0.001, compared 
to MC3T3 cells co-cultured with LNShh cells at indicated 
time points. (B) Effect on ALP activity. Mixed cultures of 
MC3T3 cells with either control LNCaP or LNShh cells were 
grown in 6-well plates. Quantitative ALP activity was deter-
mined in cell lysates at indicated time points. ALP activity in 
mixed cultures of MC3T3 and LNShh cells (filled bars) were 
compared to those in mixed cultures of MC3T3 and control 
LNCaP cells (open bars). Data are means ± SD of 6 replicate 
determinations from 3 independent samples for each group. 
*, P < 0.05. (C) Localization of ALP activity. Mixed cultures of 
MC3T3 cells with either control LNCaP or LNShh cells were 
grown in 6-well plates and stained for ALP activity at indi-
cated time points. Magnification, 10×. (D) Effect on Akp2 
expression. MC3T3 cells were grown in mixed culture with 
either LNCaP or LNShh cells. Expression of Akp2 in MC3T3 
cells cultured with LNShh cells (filled bars) relative to those 
cultured with control LNCaP cells (open bars) were com-
pared. (E) MC3T3 cells were cultured alone in the absence 
(open bar) or presence (filled bar) of 1 μg/ml Shh-N for 24 h, 
and their relative Akp2 expression was compared. In (D) and 
(E), values are means ± SD of 2–5 assays. *, P < 0.05.
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binding site but not activate the pathway, thus, acting as a
dominant negative form of the Shh signalling transcrip-
tion factor.
Both parental MC3T3 and the M-TAD cells expressed
endogenous mouse Gli1 mRNA (Figure 4A, lanes 1 and
2). However, only M-TAD cells expressed the message for
the dominant negative human GLI(-)TAD transgene (Fig-
ure 4A, lanes 3 and 4). Surprisingly, the phenotype of M-
TAD cells appeared different from that of parental MC3T3
cells. When grown to confluence, MC3T3 cells changed
from a spindle-shaped phenotype to a cuboidal morphol-
ogy with generally round nuclei indicative of the differen-
tiated state (Figure 4B, panel a). M-TAD cells, on the other
hand, retained their fusiform shape with nuclei elongated
along the long cell axis consistent with an immature oste-
oblast state (Figure 4B, panel b). As with MC3T3 cells, M-
TAD cells in mixed culture with LNShh cells formed a
stroma surrounding human prostate cancer cells although
their stroma appeared to be more compact (Figure 4B,
panels c and d).
Expression of the dominant negative GLI1 effectively
blocked the activation of the Shh pathway and inhibited
the upregulation of Gli1 and Ptc1 in M-TAD cells cultured
with LNShh cells (Figure 4C). Consequently, M-TAD cells
cultured with LNShh cells for 14 days exhibited markedly
decreased Akp2 expression (data not shown) and ALP
activity (Figure 4D, panels a, b and c). Hematoxylin stain-
ing of mixed cultures following staining for ALP activity
showed confluent populations of both MC3T3 and M-
TAD cells in mixed cultures with LNShh cells indicating
that the decrease in ALP activity in M-TAD cells was not a
function of differences in cell confluence in the co-cul-
tures (Figure 4D, panels d, e and f).
LNShh cells do not upregulate the expression of Runx2
The transcription factor Runx2 plays a pivotal role in oste-
oblast differentiation and function [17,18]. The effect of
LNShh cells on Runx2 expression in MC3T3 cells in mixed
cultures was determined. Endogenous levels of Runx2
were not significantly changed in MC3T3 cells cultured
with LNShh cells (Figure 5A, b relative to a). In addition,
the expression of Runx2 target genes osteocalcin (Ocn)
and osteopontin (Opn) were not significantly increased
(Figure 5A, c and d, respectively, relative to a).
Consistent with these data, activation of the Shh pathway
in MC3T3 cells by exogenous Shh-N, as evidenced by
increased expression in Gli1 and Ptc1, did not upregulate
Runx2 expression (Figure 5B). On the other hand, exoge-
nous AA significantly increased Runx2 levels in MC3T3
cells without activating the Shh pathway (Figure 5B).
Combined stimulation with Shh-N and AA did not signif-
icantly increase the expression of Runx2 relative to treat-
ment with AA alone, or the expression of Shh target genes
Gli1 and Ptc1 relative to treatment with Shh-N alone indi-
cating the absence of synergistic interaction between these
two factors. AA upregulates the expression of osteoblast
differentiation marker genes including Runx2 and pro-
motes osteoblast differentiation [19,20]. These data,
therefore, indicate that early phase osteoblast differentia-
Dominant negative Gli1 inhibits paracrine Shh signalling and osteoblas  differentiat onFigure 4
Dominant negative Gli1 inhibits paracrine Shh signal-
ling and osteoblast differentiation. (A) MC3T3 cells 
were stably transfected with human GLI1 cDNA with deleted 
region containing the trans activation domain: pCMV-GL1(-
)TAD. Expression of mouse endogenous Gli1 (mGli1) and 
human GLI1-TAD transgene in parental MC3T3 cells and 
transfected cells, designated M-TAD cells, were determined 
by conventional RT-PCR analysis. The mouse gene for ribos-
omal protein 19 (mrpl19) was used as housekeeping gene. (B) 
Hematoxylin staining of single cultures of MC3T3 and M-
TAD cells are shown in panels a and b, respectively. Fluores-
cent microscopy images of 14-day mixed cultures of MC3T3 
and LNShh cells or M-TAD and LNShh cells are shown in 
panels c and d, respectively. The photomicrograph of mixed 
culture of MC3T3 and LNShh cells shown in panel c is the 
same as that shown in Figure 1 panel c, except only phalloidin 
staining and GFP expression are revealed here. Scale bars: 25 
μm (a, b) and 50 μm (c, d). (C) MC3T3 cells or M-TAD cells 
were grown for 14 days in 6-well plates with culture inserts 
containing either LNCaP or LNShh cells (separate co-cul-
tures). Expression of Gli1 and Ptc1 in MC3T3 or M-TAD cells 
co-cultured with LNShh cells (filled bars) relative to those 
co-cultured with control LNCaP cells (open bars) were com-
pared. Results are representative of 2 independent experi-
ments. (D) Mixed cultures of MC3T3 and M-TAD cells with 
either LNCaP or LNShh cells were grown in chamber slides 
for 14 days and stained for ALP activity (panels a, b and c) fol-
lowed by hematoxylin staining (panels d, e and f). Scale bars: 
50 μm.
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tion in pre-osteoblasts induced by paracrine Shh signal-
ling might proceed in a mechanism that does not require
the transcriptional regulation of Runx2.
Discussion
The functional relevance of upregulated Shh expression in
human prostate carcinoma to the development of bone
metastasis has not been previously investigated. We now
provide data which indicate that prostate cancer cells that
express high levels of Shh can directly and specifically acti-
vate the signalling pathway in osteoblast progenitors and
induce osteoblast differentiation, an essential process in
new bone formation that characterizes prostate carcinoma
metastasis.
LNCaP human prostate cancer cells genetically engineered
to overexpress Shh (designated LNShh cells) upregulated
the expression of Shh-responsive target genes Gli1 and
Ptc1 in co-cultured MC3T3 mouse pre-osteoblasts and this
action was inhibited by cyclopamine, a specific chemical
inhibitor of hedgehog signalling, and mimicked by exog-
enous Shh peptide. LNShh cell-induced activation of the
Shh signalling pathway in pre-osteoblasts led to the
induction of early phase osteoblast differentiation charac-
terized by abrogated cell proliferation and increased
expression and activity of alkaline phosphatase. Con-
versely, failure to activate the Shh pathway by a dominant
negative form of the transcription factor Gli1 in pre-oste-
oblasts inhibited LNShh cell-induced osteoblast differen-
tiation. These data confirm previous findings which have
demonstrated a role for the hedgehog proteins, Shh and
Indian hedgehog (Ihh), in osteoblast differentiation [21-
27].
Ihh, Ptc1, Smo, Gli1, Gli2, and Gli3 are expressed in devel-
oping bone, and hedgehog signalling plays a vital role in
skeletal development [28-35]. The expression of Ptc1,
Smo, and Gli1 in perichondrial cells adjacent to Ihh-
expressing prehypertropic chondrocytes strongly suggests
a paracrine pathway through which hedgehog signalling
might induce differentiation of perichondrial cells into
osteoblasts during endochondral bone formation
[21,30,34,35].
Our data suggest that the apparent paracrine pathway of
hedgehog signalling in bone development may be recapit-
ulated in bone metastasis where Shh-expressing prostate
cancer cells activate the pathway in osteoblast progenitors
and induce osteoblast differentiation. Reciprocally, differ-
entiated osteoblasts might provide factors that are favour-
able to tumor growth in bone. Many identified
downstream target genes of Gli1 transcriptional activity
are known to regulate cell proliferation and cell adhesion
[36].
The downstream mechanism through which Shh signal-
ling induces osteoblast differentiation is not fully under-
stood. Runx2 (also known as Cbfa1: core-binding factor 1)
encodes a major and critical transcription activator of
osteoblast differentiation [17,37,38]. A recent study has
demonstrated that Ihh promotes osteoblast differentia-
tion in multipotent mesenchymal cells C3H10T1/2 by
upregulating the expression and function of Runx2
LNShh cells do not upregulate Runx2 expression in MC3T3 cellsFigure 5
LNShh cells do not upregulate Runx2 expression in 
MC3T3 cells. (A) MC3T3 cells were grown in mixed cul-
tures with either LNCaP or LNShh cells. Expression of 
Runx2, Ocn, and Opn in MC3T3 cells cultured with LNShh 
cells (filled bars) relative to those cultured with control 
LNCaP cells (open bars) were compared. (B) MC3T3 cells 
were cultured alone for 24 h without (-) or with (+) 1 μg/ml 
Shh-N or 50 μg/ml AA as indicated. Levels of expression of 
Runx2, Gli1 and Ptc1 among groups were compared. All val-
ues are means ± SD from 2–3 independent experiments. *, P 
< 0.05.
(A)
b Runx2
c Ocn
d Opn
(B)
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through the transcriptional action of Gli2 [27]. Our data,
however, show that LNShh cell-induced early phase dif-
ferentiation in MC3T3 pre-osteoblasts was not accompa-
nied by a significant increase in endogenous levels of
Runx2 and its downstream target genes Ocn and Opn.
Moreover, exogenous Shh-N did not directly upregulate
Runx2 expression in MC3T3 cells; whereas, the osteoblast
differentiation factor AA increased Runx2 levels in MC3T3
cells without activating the Shh pathway. These data sug-
gest that in cells that are already committed to the osteob-
last lineage and express endogenous levels of Runx2, as is
the case with MC3T3 cells, the induction of osteoblast dif-
ferentiation by Shh signalling occurs through a mecha-
nism that does not require further transcriptional
upregulation of Runx2. Similarly, Xiao and co-workers
concluded that osteoblast differentiation induced by bone
morphogenetic protein (BMP) in mature osteoblast pre-
cursors does not require increased expression of Cbfa1
(Runx2) but might involve posttranscriptional regulation
of the Runx2 protein [39]. In multipotent mesenchymal
progenitors, however, Shh signalling promotes osteoblast
commitment and differentiation through the upregula-
tion of Runx2 message and activity [27,40].
Shh may act in concert with other factors in regulating
osteoblast differentiation. Prostate cancer cells secrete sig-
nalling ligands including growth factors, bone morphoge-
netic proteins, and parathyroid hormone-related protein
which are known to regulate osteoblast functions and
whose actions have been linked to hedgehog signalling
[5,6,24,41,42]. More studies are needed to tease out the
functional interplay between hedgehog signalling and
other pathways in the development of prostate carcinoma
metastasis in bone.
Prostate cancer cells that metastasize to bone or those that
are directly injected in bone in animal models will be in
close physical contact with bone stromal cells including
bone cells and their osteoblast progenitors, fibroblasts,
hematopoetic cells, and multipotent mesenchymal stem
cells. In the presence of mixed cell populations within the
bone environment, it is difficult to isolate and determine
direct cell-cell interactions that might impact the develop-
ment of prostate carcinoma metastasis. The non-conven-
tional mixed culture system developed in these studies
provides an excellent in vitro model to investigate early
outcomes of paracrine signalling between defined cell
populations and to evaluate how these interactions might
be impacted by other signalling pathways and/or thera-
peutic interventions.
Conclusion
This study presents evidence that Shh-expressing prostate
cancer cells directly and specifically activate the Shh sig-
nalling pathway in pre-osteoblasts. Paracrine Shh signal-
ling in pre-osteoblasts leads to osteoblast differentiation
via a Gli1-dependent mechanism that does not require
transcriptional upregulation of endogenous Runx2 expres-
sion. These data provide a mechanism through which
increased levels of Shh in human prostate carcinoma
might specifically promote bone metastasis.
Methods
Plasmid Transfections
LNCaP human prostate cancer cells (ATCC, Rockville,
MD) have been previously stably transfected with a 1.44
kb human Shh cDNA cloned into a pIRES2-EGFP mam-
malian cell expression vector (designated as LNShh cells)
or with pIRES2-EGFP vector alone [9]. LNShh and control
LNCaP cells were maintained at 37C, 5% CO2 in complete
culture medium consisting of RPMI-1640 supplemented
with 10% fetal bovine serum (FBS), 100 U/ml penicillin
and 100 μg/ml streptomycin (Gibco Invitrogen). Shh
gene and protein expression were routinely determined by
quantitative real time RT-PCR and western blot analysis,
respectively, and GFP expression was monitored by fluo-
rescence microscopy.
Cells from the mouse calvaria-derived non-transformed
pre-osteoblast cell line MC3T3-E1 (subclone 4; ATCC,
Rockville, MD: designated as MC3T3 cells), were trans-
fected with pCMV-GLI(-)TAD: a human GLI1 cDNA lack-
ing a trans activation domain and cloned into pcDNA3
plasmid (kindly provided by Drs. Joon Won Yoon and
David Walterhouse, Children's Memorial Research
Center, Northwestern University Feinberg School of Med-
icine, Chicago, IL). The pCMV-GLI(-)TAD was previously
prepared by deleting a 1,409-bp AccI fragment from the 3'
end of human GLI1 cDNA [16]. MC3T3 cells were trans-
fected with 3 μg DNA using the Effectene reagent accord-
ing to manufacturer's protocol (Qiagen), selected for
stable transfection with G418 (Sigma), and cloned by lim-
iting dilution (designated M-TAD cells). Parental MC3T3
and M-TAD cells were maintained at 37C, 5% CO2 in non-
differentiation complete culture medium consisting of
ascorbic acid (AA)-free α-MEM supplemented with 10%
FBS, 100 U/ml penicillin and 100 μg/ml streptomycin
(Gibco Invitrogen).
Mixed Culture of Cells
Control LNCaP or LNShh cells (5 × 104) and MC3T3 cells
(0.5 × 104) were mixed in AA-free α-MEM complete cul-
ture medium and seeded per well of 6-well tissue culture
plates. Cultures were maintained for the length of time
specified in the experiments with media changes every 2–
3 days.
Separate Co-culture of Cells
Control LNCaP or LNShh cells (5 × 104) were seeded per
cell culture insert (transparent PET membrane, 0.4 μm
Molecular Cancer 2009, 8:12 http://www.molecular-cancer.com/content/8/1/12
Page 9 of 11
(page number not for citation purposes)
pore size: BD Biosciences) in RPMI-1640 complete culture
medium. MC3T3 cells (1 × 104) were seeded per well of 6-
well tissue culture plates in AA-free α-MEM complete cul-
ture medium. After two days, culture inserts grown with
prostate cancer cells were transferred to wells grown with
MC3T3 cells, and co-cultures were maintained in AA-free
α-MEM complete culture medium for the length of time
specified in the experiments with media changes every 2–
3 days.
RNA Isolation and Real Time Quantitative RT-PCR
Total RNA was extracted using Trizol (Invitrogen), puri-
fied using the RNeasy Mini Kit (Qiagen) and subjected to
DNase treatment with RQ1 RNase-free DNase (Promega)
to remove contaminating genomic DNA. The TaqMan®
Gold PCR Core Reagent Kit along with MuLV Reverse
Transcriptase and RNase Inhibitor (Applied Biosystems)
were used for cDNA synthesis. PCR primers (Invitrogen)
and FAM-QSY7 probes (MegaBases, Inc.) for genes of
interest and the housekeeping gene glyceraldehyde-3-
phosphate dehydrogenase (Gapdh), whose sequences are
shown in Table 1, were designed using the Primer Express
3.0 software program. mRNA expression was measured in
duplicate or triplicate per sample using 40 cycles of ampli-
fication in the 7500 Fast Real-Time PCR System (Applied
Biosystems). Reactions were routinely performed without
Reverse Transcriptase to demonstrate RNA dependence of
the reaction products. Results were analyzed using the
comparative Ct method. Ct is the threshold cycle at which
the reporter fluorescence signal for each amplicon passes
above a fixed baseline. The average Ct of the gene of inter-
est was normalized to that of the housekeeping gene
Gapdh to obtain the ΔCt for that gene. ΔCt values between
experimental and control samples were then compared
(ΔΔCt) to reflect the relative fold change in gene expres-
sion.
Cell Proliferation Assay
Cells were maintained as separate co-cultures as described
above. MC3T3 cells were seeded onto 24-well tissue cul-
ture plates at 0.2 × 104 cells per well. Control LNCaP or
LNShh cells were seeded at 2 × 104 cells per cell culture
insert. Following overnight incubation, culture inserts
were transferred to wells and co-cultures were maintained
in AA-free α-MEM complete culture medium with media
changes every 2–3 days. At specified times, cell inserts
were removed and proliferation of MC3T3 cells grown on
wells was determined using the Cell Counting Kit-8
(Dojindo Laboratories, Japan) which is based on the for-
mation of a water-soluble formazan dye through the activ-
ity of dehydrogenases in living cells.
Immunocytochemistry and Immunofluorescence
Cells were maintained as mixed cultures in Lab-TekII
CC2-treated chamber slides (Nunc) for the length of time
specified in the experiments with media changes every 2–
3 days. Cells were then fixed in 10% neutral buffered for-
malin for 10 minutes and permeated with 0.1% Triton X-
100. For fluorescence immunocytochemistry, cells were
stained with Alexa Flour 635 Phalloidin (Invitrogen: 1:40
dilution) and incubated in the dark for 20 minutes. Cells
were counter-stained with 300 nM DAPI (Invitrogen).
Slides were mounted using ProLong Gold antifade reagent
(Invitrogen). For cytokeratin expression, fixed cells were
stained with mouse monoclonal anti-human cytokeratin
8 antibody (DAKO: 1:50 dilution), developed with diami-
nobenzidine, and counterstained with hematoxylin.
Slides were viewed in a Leica DMR-HC Upright Micro-
scope and images were captured with imaging software
(Improvision Openlab). Fluorescent images were cap-
tured at the following excitation/emission wavelengths
(nm): Phalloidin-560/645; DAPI-360/470; GFP-480/527.
Alkaline Phosphatase Activity
Quantitative determination of ALP activity was done
using the p-Nitrophenyl Phosphate (pNPP) Liquid Sub-
strate System according to manufacturer's protocol
(Sigma Aldrich). Briefly, cells in culture wells were treated
with 0.2% Triton X-100, harvested with a cell scraper, and
subjected to freeze-thaw cycles. Lysates were centrifuged
and supernatants (10 μg protein) were incubated with
150 μl pNPP for 5 h at room temperature in the dark.
Absorbance at 405 nm was measured using a microplate
reader, and ALP activity was calculated according to man-
ufacturer's instructions. Protein determination was done
using the Bio-Rad DC Protein Microplate Assay according
to manufacturer's protocol.
For ALP staining, mixed cultures were fixed with 10% neu-
tral buffered formalin for 10 minutes and incubated with
alkaline phosphatase substrate solution for at least 30
minutes at room temperature in the dark. The substrate
solution was prepared by adding Naphthol AS-MX Phos-
phate Alkaline Solution to a diazonium salt solution (Fast
Violet B Salt capsule dissolved in distilled water) just
before use (Sigma-Aldrich).
Effect of Shh peptide
MC3T3 cells were seeded onto 6-well culture plates at 1 ×
105 cells per well in AA-free α-MEM complete culture
medium. Following overnight incubation, cells were
treated with 1 μg/ml Shh-N, a modified active N-terminal
peptide of human Shh (kindly provided by Curis Inc.,
Cambridge, MA), in serum-free AA-free α-MEM culture
media for 24 h or 72 h.
Inhibition of Shh Signalling by Cyclopamine
Cultures of mixed cells (as described above) were main-
tained for 6 days in serum-free AA-free α-MEM culture
medium with 1 or 10 μM cyclopamine (vehicle controls
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were 0.01 or 0.1% ethanol, respectively). Cyclopamine, a
generous gift from Dr. W. Gaffield (Western Regional
Research Center, USDA, Albany, CA), has been previously
used to inhibit Shh signalling in developing mouse pros-
tate [43].
Effect of Ascorbic Acid
Cultures of mixed cells (as described above) were main-
tained for 7 days in AA-free α-MEM complete culture
medium without or with 50 μg/ml L-ascorbic acid (AA;
Sigma). To determine the direct effect of AA, MC3T3 cells
were seeded alone onto 6-well culture plates at 1 × 105
cells per well in AA-free α-MEM complete culture
medium. Following overnight incubation, cells were
treated without or with 50 μg/ml AA for 24 h.
Data Analysis
Data were analyzed by ANOVA and pairwise multiple
comparisons were done using the Bonferroni t-test at P <
0.05. Data are presented as means ± SD of at least 2 assays
from independent experiments, each assay done in dupli-
cate or triplicate.
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